How Long Does a Mounjaro Pen Last Once Opened?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide injection therapy requires careful handling to maintain drug stability and effectiveness. Understanding the timeline for an opened Mounjaro pen helps patients plan refills, avoid waste, and maintain consistent dosing schedules without interruption.

How Long Does an Opened Mounjaro Pen Last

Once punctured with a needle, a Mounjaro pen maintains full potency for exactly 28 days when stored properly in a refrigerator between 36°F and 46°F. This 28-day window is the manufacturer's established stability window, after which the medication's integrity cannot be guaranteed. The countdown begins at the moment of first needle insertion, not at the date of dispensing or when you first read the label.

Temperature consistency matters significantly for this timeline. If a Mounjaro pen is exposed to room temperature or warmer conditions for extended periods, the degradation clock may accelerate beyond the standard 28-day window. Patients traveling or in climates without reliable refrigeration should consider this limitation when planning their treatment schedule or discussing alternatives with their provider.

Storage Requirements and Temperature Control

Mounjaro pens must remain refrigerated at all times once opened, with a tight temperature range of 36°F to 46°F being optimal for medication stability. Storing an opened pen in a freezer or at temperatures below 36°F can alter the drug's formulation, while temperatures above 46°F accelerate molecular breakdown and shorten the usable timeline. A standard kitchen refrigerator shelf works well, but keeping the pen away from the back wall or freezer compartment prevents accidental freezing.

Before each injection, an opened Mounjaro pen should be allowed to sit at room temperature for 10 to 15 minutes to improve comfort and reduce injection-site discomfort. However, this brief time outside the refrigerator does not count against the 28-day stability window—only continuous storage conditions affect the overall shelf life. Patients should mark the date of first use on their pen with a permanent marker to avoid confusion about when to discard the remaining medication.

What Happens if a Mounjaro Pen Is Left Unrefrigerated

Leaving an opened Mounjaro pen at room temperature gradually degrades the tirzepatide compound, reducing its potency and potentially compromising weight loss and blood sugar outcomes. Even brief periods of warmth—such as sitting on a countertop during meal preparation—begin to destabilize the medication at a molecular level. Extended exposure (more than a few hours) significantly increases the risk that remaining doses will be less effective when injected.

If a Mounjaro pen has been left unrefrigerated and you cannot determine exactly how long it sat out, discard it rather than risk an ineffective or potentially unstable injection. The cost of discarding a partial pen is lower than the risk of altered medication affecting your treatment goals. For patients in hot climates or those who travel frequently, discussing alternative delivery formats or compounded options with their healthcare provider may offer more practical solutions.

PlexusDx Compounded Tirzepatide: A Consistent Alternative

PlexusDx offers compounded tirzepatide injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, prepared by licensed 503A compounding pharmacies and shipped directly to patients in all 50 states without insurance requirements. Compounded tirzepatide provides the same active ingredient as brand-name Mounjaro but with flexible dosing schedules and personalized formulation options that eliminate the stress of rigid 28-day timelines or travel-related storage concerns. Many patients find compounded delivery more convenient when coordinating injections with their lifestyle or managing supply continuity.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I extend the 28-day timeline by refreezing an opened Mounjaro pen?

No. Once a Mounjaro pen is opened and has thawed from frozen storage, refreezing does not extend its 28-day stability window and may damage the drug formulation. Always discard an opened pen after 28 days or if it has been exposed to freezing temperatures, regardless of remaining doses.

What clinical evidence supports the 28-day stability claim?

Eli Lilly's stability studies, submitted to the FDA during Mounjaro's approval process, demonstrated that tirzepatide maintains potency for 28 days post-opening when stored at 36-46°F. Real-world pharmacy and clinical data consistently align with this timeline, confirming the reliability of the 28-day window for patient safety and efficacy.

How does PlexusDx compounded tirzepatide pricing work compared to brand Mounjaro?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan)—a flat, dose-independent price with no insurance required and HSA/FSA eligibility. Brand Mounjaro's copay or list price often exceeds this, and compounded formulations eliminate the 28-day discard pressure by offering flexible refill scheduling tailored to your treatment plan.

Is compounded tirzepatide from PlexusDx as safe and effective as Mounjaro?

PlexusDx compounded tirzepatide is prepared by licensed 503A compounding pharmacies using the same active pharmaceutical ingredient as Mounjaro, meeting FDA-established compounding standards. While not FDA-approved as a brand product, compounding-pharmacy-prepared tirzepatide has a well-documented safety profile in clinical use and provides identical therapeutic action when dosed correctly.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Do Genetics Affect How Long My Reproductive Years Will Last
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.